A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthma-Reference-Cited by-同舟云学术

A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthma

Published:2020-02-05 Issue:4 Volume:55 Page:882-889
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol

Author:

Weinstein Cindy L. J.¹^ORCID,Gates Davis¹,Zhang Xiaoli¹,Varnell Tracey¹,Mok Wilson¹,Vermeulen Jan H.²,Amar Niran J.³,Jain Neal⁴

Affiliation:

1. Merck & Co Inc Kenilworth New Jersey

2. Panorama Medical Centre Panorama Cape Town South Africa

3. Allergy Asthma Research Institute Waco Texas

4. Arizona Allergy and Immunology Research LLC Gilbert Arizona

Funder

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.24667

Reference19 articles.

1. P211 EFFICACY AND SAFETY OF MOMETASONE FUROATE/FORMOTEROL COMPARED WITH MOMETASONE FUROATE IN CHILDREN WITH PERSISTENT ASTHMA

2. Centers for Disease Control and Prevention. Most recent national asthma data.https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm. Accessed May 1 2019.

3. Global Initiative for Asthma.https://ginasthma.org/. Accessed January 18 2019.

4. US prescribing information for ASMANEX® HFA (mometasone furoate).https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205641s007s008lbl.pdf. Accessed May 1 2019.

5. US prescribing information for ASMANEX® TWISTHALER®110 mcg 220 mcg (mometasone furoate inhalation powder)https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021067s026 s028lbl.pdf. Accessed May 1 2019.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance Therapy for Children and Adolescents with Asthma: Guidelines and Recommendations from the Emilia-Romagna Asthma (ERA) Study Group;Journal of Clinical Medicine;2023-08-23

2. Identification of Four Enhancer-Associated Genes as Risk Signature for Diffuse Glioma Patients;Journal of Molecular Neuroscience;2021-08-31

3. Pediatric Pulmonology 2020 year in review: Asthma;Pediatric Pulmonology;2021-06-02